Fumarate can be a surrogate for O2 as a terminal electron acceptor in the electron transport…
dcorriganJune 17, 2022
Critically ill patients manifest many of the same immune features seen in COVID-19, including both…
dcorriganJune 16, 2022
Seattle Children’s Research Institute today announced the Invent at Seattle Children’s Postdoctoral Scholars Program, a $45…
dcorriganJune 16, 2022
Dr. Melody Campbell, a structural biologist at Fred Hutchinson Cancer Center, was named today a…
dcorriganJune 15, 2022
An RNA-focused therapeutics company, Seattle-based Shape Therapeutics has developed a technology that is allowing it to…
dcorriganJune 15, 2022
Cancer clinical trials have long had a disparity problem, but a new push for more…
dcorriganJune 14, 2022
Ensuring good health for all is a tall order, and organizations within marginalized communities are…
dcorriganJune 14, 2022
Prolific biotech co-founder and University of Washington scientist David Baker, head of the UW Institute…
dcorriganJune 14, 2022
Umoja Biopharma, an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells to treat…
dcorriganJune 13, 2022
